FIELD: pharmaceutical engineering; medical engineering.
SUBSTANCE: method involves carrying out nuclear magnetic resonance tomography of human or animal blood circulation system containing chelating ion complexes of bivalent and valence three paramagnetic metals of (I)X-L-Y formula, where X is the polyamide carbonyl ligand residue and Y is the gallic acid derivative, 
.
EFFECT: high accuracy of diagnosis.
28 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING GAMMA AMIDES OF GLUTAMIC ACID | 1999 |
|
RU2395490C2 |
| IMPROVED PEPTIDE GASTRIN-RELEASING COMPOUNDS | 2003 |
|
RU2330859C2 |
| ROR-GAMMA MODULATORS | 2012 |
|
RU2658013C2 |
| DEUTERATED DERIVATIVE OF CHENODEOXYCHOLIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUND | 2016 |
|
RU2712033C2 |
| AGENTS FOR INHIBITING ENZYME TYROSYL-DNA-PHOSPHODIESTERASE 1 BASED ON BILE ACIDS | 2018 |
|
RU2689335C1 |
| DOUBLE METAL CYANIDE CATALYSTS FOR PRODUCTION OF POLYETHERPOLYOLS | 2000 |
|
RU2235589C2 |
| DOUBLE METAL CYANIDE-BASED CATALYSTS FOR PRODUCTION OF POLYETHER(ESTER)POLYOLS | 2000 |
|
RU2254164C2 |
| CONJUGATES OF 4-BENZYLAMINOQUINOLINES WITH BILE ACID AND THEIR HETEROANALOGS, METHOD FOR THEIR PREPARING AND DRUGS BASED ON THESE COMPOUNDS | 2000 |
|
RU2247125C2 |
| BILE ACID-SUBSTITUTED PHENYLALKENOYLGUANIDINES, MEDICINAL AGENT | 1999 |
|
RU2232769C2 |
| METHOD FOR ENZYME REGENERATION OF REDUCTIVE-OXIDATIVE COFACTORS | 2013 |
|
RU2635087C2 |
